top of page

Second round of COVID booster sought as concerns of efficacy after six months for immune-compromise

As new-case COVID numbers maintain a downward trend, both drug manufacturers Pfizer and Moderna are asking the Federal Drug Administration and Centers for Disease Control for a recommendation for yet another booster in the vaccination protocol.

Want to read more?

Subscribe to to keep reading this exclusive post.



לא היה ניתן לטעון את התגובות
נראה שהייתה בעיה טכנית. כדאי לנסות להתחבר מחדש או לרענן את הדף.
bottom of page